MedTrace Logo

The PRIMAVERA Study: Reduxine Safety Monitoring in Patients With Alimentary Obesity

NCT01773733 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98774

Last updated 2024-01-19

Study results available
· View outcomes & findings →

Summary

The aim of this study is to summarize the data on efficacy and safety of Reduxine administration in the routine clinical practice according to the approved indications.

Conditions

  • Alimentary Obesity

Sponsors & Collaborators

  • Promomed, LLC

    lead OTHER

Principal Investigators

  • Ivan I Dedov, academician · FEDERAL STATE BUDGETARY INSTITUTION "ENDOCRINOLOGY RESEARCH CENTRE" MINISTRY OF HEALTH OF RUSSIA

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-07-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01773733 on ClinicalTrials.gov